March 18, 2013 -- SFL is pleased to announce the constitution of its company Advisory Board. The SFL Advisory
Board Members combine a broad range of expertise covering in
-
depth knowledge of
regulatory and policy developments, legal standards, science, medicine and company
i
nfrastructures. Thus, they will provide strategic advice and recommendations on the long
-
term development of SFL and our clients. The Advisory Board will be chaired by Mrs. Silvia
Matile
-
Steiner, former Head Government/Public Affairs at F. Hoffmann
-
La Roch
e.
,
“SFL is witnessing an exciting period of growth and the formation of our Advisory Board will
assist us in our future plans,” commented Shayesteh Fürst
-
Ladani, Managing Director of SFL.
“As recognized and experienced practitioners or former practitioners
in their fields of
expertise their involvement represents an invaluable resource for the company”.
,
SFL Advisory Board Members include:
,
Silvia Matile
-
Steiner,
LLM
,
Mrs. Silvia Matile
-
Steiner is an expert in public affairs and has extensive professional
expe
rience in legal affairs, communications, public relations and government affairs.
Previously, she was Head Government/Public Affairs at corporate level at F. Hoffmann
-
La
Roche headquarters. Her work spanned, in particular, diverse research areas such as
pe
rsonalized healthcare, clinical trials and diagnostics. She was in regular contact with EU as
well as Swiss key opinion leaders.
,
Per Helboe, MSc, PhD, DSc
,
Professor Per Helboe is an expert in regulatory affairs and provides strategic advice on
quality
-
and
regulatory
-
related matters for products. He is Professor in Regulatory Affairs at
the University of Copenhagen, Faculty of
Health and Medical Sciences
, and was Senior
Director and Head of the Licensing Division of the Danish Medicines Agency from 2001 unt
il
his retirement in 2011.
,
Bruno Maier, PhD, LLM
,
Dr Bruno Maier is a qualified lawyer (PhD, Attorney
-
at
-
law, LLM) with in
-
depth practical
experience in international commercial law. Dr Maier was Director and General Counsel
with world
-
wide responsibility a
t F. Hoffmann
-
La Roche headquarters before his retirement.
,
Claire Barton, MA MB BChir MRCP PhD FFPM
,
Dr Claire Barton is a medical oncologist/pharmaceutical physician specializing in the clinical
development of products for oncology indications. She is
a member of the Oncology Special
Interest Group of the Faculty of Pharmaceutical Medicine in the UK, and acts as a Senior
Specialty Advisor for pharmaceutical physicians undertaking higher medical training in
Pharmaceutical Medicine.
,
Friedlieb Pfannkuch, M
D
,
Professor Friedlieb Pfannkuch is a qualified pathologist (anatomical pathology) and
President of the Swiss Society of Toxicology. He is an expert in
non
-
clinical safety with
extensive experience in experimental toxicology and assessment of all stages of
drug
development.
,
About SFL Regulatory Affairs & Scientific Communication Ltd
,
SFL is dedicated to a holistic approach to lifecycle management of healthcare products from
non
-
clinical and clinical studies through to
registration and post
-
approval activities. The SFL
team members have experience in Regulatory Affairs, Public Affairs, Legal Services and
Medical Communications, and provide personalized and comprehensive services. When
combined, these services comprise an
integral oversight package for products from the
bench to the marketplace at one consultancy. SFL also provides specialized training courses
where participants can benefit from the team’s cross
-
functional expertise
.
For more information, please contact:,
Faiz Kermani, PhD
Senior Communication Manager
SFL Regulatory Affairs & Scientific Communication Ltd
Hochstrasse 51
,
CH
-
4002 Basel,
Switzerland
Tel: +41 61 361 9443
Fax: +41 61 361 9442
Email: office@sfl
-
services.com
Web: www.sfl
-
services.com